ÂÜÀòÂÒÂ×

Dannette Doolittle has extensive experience in the pharmaceutical and biotechnology industry. Dannette is currently employed as the Associate Director of Project and Portfolio Management at Vir Biotechnology, Inc. Prior to this, they worked at Vapogenix Inc. as the Associate Director and Principal Project Manager. Here, they successfully managed a Phase II clinical trial and ensured quality and timeliness through effective management of manufacturing and clinical outsourcing partners.

Before joining Vapogenix, Dannette served as the Director of the Pharmaceutical Development Center at MD Anderson Cancer Center, where they directed operational activities and participated in strategic planning for non-clinical and early phase clinical drug development.

Earlier in their career, they held positions at ABC Laboratories, Aptuit, Quintiles, and Eli Lilly and Company, where they gained experience in project management, bioanalytical services, and analytical chemistry.

Overall, Dannette's work experience demonstrates their expertise in project and portfolio management, clinical trial management, and operational leadership in the pharmaceutical and biotechnology industry.

Dannette Doolittle holds a Ph.D. in Bioanalytical Chemistry from The University of Kansas and a Bachelor of Science (B.S.) degree in Chemistry from Nebraska Wesleyan University. Additionally, they obtained a certification in Good Clinical Practice (GCP) from The National Institute on Drug Abuse (NIDA) Clinical Trials Network in February 2020.